Mayo Clinic Health System-Southeast Minnesota Region
Mayo Clinic Health System-Southeast Minnesota Region was paid $13.72M by Medicaid between Jan 2018 and Dec 2024, across 241 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 19% of everything it billed.
OWATONNA, MN 55060
Next to other Multi-Specialty Clinic/Center providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 89,145 | $774K | |
| 2019 | 85,311 | $2.78M | |
| 2020 | 74,579 | $2.26M | |
| 2021 | 118,415 | $2.67M | |
| 2022 | 95,586 | $2.26M | |
| 2023 | 72,244 | $1.68M | |
| 2024incomplete | 56,214 | $1.29M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 62,742 | 56,987 | $2.66M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 42,945 | 39,466 | $2.61M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.0% | 17,241 | 16,201 | $1.10M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.4% | 8,157 | 7,605 | $737K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.5% | 4,164 | 3,959 | $338K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.4% | 11,264 | 11,041 | $329K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.3% | 4,878 | 4,761 | $311K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.2% | 20,581 | 18,043 | $304K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.1% | 8,101 | 7,750 | $283K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.6% | 3,297 | 3,256 | $223K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.5% | 9,695 | 9,454 | $211K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 4,079 | 3,951 | $210K |
229 more codes
| 36415 | Collection of venous blood by venipuncture | 1.5% | 56,017 | $207K |
| X5622 | 1.5% | 5,027 | $207K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 2,898 | $196K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.2% | 2,342 | $168K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 4,688 | $156K |
| 99203 | Doctor's office visit, new patient (routine) | 1.0% | 2,572 | $141K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,377 | $133K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12,374 | $122K |
| 87631 | <1% | 836 | $112K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 18,219 | $104K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,304 | $103K |
| 80061 | Lipid panel | <1% | 9,854 | $100K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,286 | $92K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,177 | $91K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,155 | $88K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,425 | $83K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,146 | $83K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,429 | $78K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 2,367 | $77K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,011 | $72K |
| 99223 | Prolong inpt eval add15 m | <1% | 655 | $66K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 10,447 | $64K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,777 | $59K |
| 92015 | Determination of refractive state | <1% | 5,260 | $57K |
| 90686 | <1% | 9,375 | $56K | |
| 87660 | <1% | 3,257 | $56K | |
| 87480 | <1% | 3,257 | $56K | |
| 87510 | <1% | 3,252 | $56K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 2,258 | $49K |
| 80053 | Comprehensive metabolic panel | <1% | 6,114 | $49K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 354 | $48K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 43 | $48K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 365 | $47K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 455 | $42K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 566 | $38K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 561 | $37K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,866 | $35K |
| 82728 | <1% | 2,715 | $32K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 770 | $31K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 635 | $31K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 445 | $31K |
| 90715 | <1% | 1,940 | $30K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,300 | $30K |
| 90651 | <1% | 1,384 | $28K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,338 | $28K |
| 85027 | <1% | 4,807 | $27K | |
| 0002A | <1% | 852 | $27K | |
| 80050 | General health panel | <1% | 570 | $26K |
| 0001A | <1% | 833 | $24K | |
| 20610 | <1% | 761 | $24K | |
| 90670 | <1% | 3,454 | $23K | |
| 92341 | <1% | 918 | $23K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 216 | $23K |
| 90750 | <1% | 225 | $23K | |
| 0240U | <1% | 151 | $20K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 200 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,410 | $18K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 4,851 | $18K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 415 | $17K |
| 99243 | <1% | 262 | $16K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,391 | $16K |
| 99188 | <1% | 1,251 | $16K | |
| 99442 | <1% | 370 | $15K | |
| 90461 | <1% | 2,951 | $15K | |
| 76801 | <1% | 194 | $15K | |
| 99177 | <1% | 287 | $14K | |
| 82565 | <1% | 3,626 | $13K | |
| 81001 | <1% | 5,389 | $13K | |
| 82570 | <1% | 2,961 | $13K | |
| 99443 | <1% | 216 | $12K | |
| 99460 | <1% | 235 | $12K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 209 | $12K |
| 76830 | Ultrasound, transvaginal | <1% | 218 | $12K |
| 81025 | <1% | 1,609 | $12K | |
| 84702 | <1% | 860 | $12K | |
| 93000 | <1% | 1,326 | $12K | |
| 82043 | <1% | 2,616 | $11K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 210 | $11K |
| 17110 | <1% | 221 | $11K | |
| 85610 | <1% | 3,849 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,853 | $10K |
| 86140 | <1% | 1,907 | $9K | |
| 84439 | <1% | 1,100 | $9K | |
| 59025 | Fetal non-stress test | <1% | 575 | $9K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 66 | $8K |
| 0004A | <1% | 236 | $8K | |
| 81003 | <1% | 4,105 | $8K | |
| 90662 | <1% | 303 | $8K | |
| 82947 | <1% | 2,424 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 162 | $8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 356 | $7K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 131 | $7K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 132 | $7K |
| 90732 | <1% | 93 | $7K | |
| 84460 | <1% | 1,559 | $7K | |
| 90677 | <1% | 35 | $6K | |
| 84450 | <1% | 1,623 | $6K | |
| 92567 | <1% | 687 | $6K | |
| 0064A | <1% | 245 | $6K | |
| 84153 | <1% | 328 | $6K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 225 | $5K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 653 | $5K |
| 73630 | <1% | 536 | $5K | |
| 36416 | <1% | 2,302 | $5K | |
| 73030 | <1% | 429 | $5K | |
| 0012A | <1% | 187 | $5K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 68 | $5K |
| 85018 | <1% | 2,223 | $5K | |
| 0072A | <1% | 118 | $4K | |
| 0071A | <1% | 110 | $4K | |
| 0124A | <1% | 143 | $4K | |
| 0054A | <1% | 130 | $4K | |
| 73610 | <1% | 476 | $4K | |
| 99496 | <1% | 39 | $4K | |
| 73562 | <1% | 228 | $4K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,610 | $4K |
| 84132 | <1% | 1,102 | $4K | |
| 92557 | <1% | 173 | $4K | |
| 99242 | <1% | 65 | $4K | |
| 92551 | <1% | 484 | $3K | |
| 0011A | <1% | 163 | $3K | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,040 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 112 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 112 | $3K |
| 90734 | <1% | 1,040 | $3K | |
| 82950 | <1% | 615 | $3K | |
| 73130 | <1% | 196 | $2K | |
| 91322 | <1% | 46 | $2K | |
| 83735 | <1% | 545 | $2K | |
| 99441 | <1% | 79 | $2K | |
| 90656 | <1% | 361 | $2K | |
| 0134A | <1% | 79 | $2K | |
| 73564 | <1% | 115 | $2K | |
| 83880 | <1% | 61 | $2K | |
| 83690 | <1% | 314 | $2K | |
| 82040 | <1% | 389 | $1K | |
| 72100 | <1% | 98 | $1K | |
| 73110 | <1% | 99 | $1K | |
| 97803 | <1% | 33 | $1K | |
| 99462 | <1% | 51 | $1K | |
| 90480 | <1% | 47 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 246 | $1K |
| 73502 | <1% | 97 | $1K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 58 | $1K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 18 | $1K |
| 90707 | <1% | 486 | $1K | |
| 90716 | <1% | 505 | $1K | |
| 76642 | <1% | 16 | $958.74 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 34 | $920.09 |
| 87070 | <1% | 204 | $893.54 | |
| 93976 | <1% | 12 | $834.82 | |
| 51798 | <1% | 170 | $822.17 | |
| 80076 | <1% | 116 | $815.84 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 138 | $776.39 |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 14 | $737.81 |
| 95886 | <1% | 12 | $689.11 | |
| 92134 | <1% | 33 | $680.74 | |
| 84156 | <1% | 207 | $635.95 | |
| 90710 | <1% | 554 | $578.70 | |
| 82248 | <1% | 134 | $519.30 | |
| 93971 | <1% | 12 | $468.36 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $426.16 |
| 99173 | <1% | 261 | $388.73 | |
| 90620 | <1% | 12 | $372.84 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 12 | $366.96 |
| 71250 | <1% | 15 | $354.66 | |
| 90697 | <1% | 193 | $353.25 | |
| 0003A | <1% | 13 | $346.05 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $314.96 |
| 82247 | <1% | 67 | $299.75 | |
| 90474 | <1% | 33 | $284.83 | |
| 84295 | <1% | 73 | $276.07 | |
| 95251 | <1% | 12 | $249.09 | |
| 73140 | <1% | 14 | $235.67 | |
| 82310 | <1% | 69 | $217.24 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 33 | $165.15 |
| 85652 | <1% | 79 | $154.70 | |
| 69209 | <1% | 13 | $127.04 | |
| 90696 | <1% | 446 | $126.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 112 | $112.47 |
| 80051 | <1% | 12 | $96.87 | |
| 99201 | <1% | 29 | $68.42 | |
| 96127 | <1% | 26 | $39.04 | |
| 90698 | <1% | 3,099 | $11.70 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 15 | $6.47 |
| 3074F | 0% | 25,982 | $0.00 | |
| 3079F | 0% | 5,089 | $0.00 | |
| 91306 | 0% | 109 | $0.00 | |
| 90744 | 0% | 1,330 | $0.00 | |
| 90680 | 0% | 1,921 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 0% | 357 | $0.00 |
| 3052F | 0% | 451 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,704 | $0.00 |
| 91305 | 0% | 197 | $0.00 | |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 9,485 | $0.00 |
| 97802 | 0% | 39 | $0.00 | |
| 3044F | 0% | 1,425 | $0.00 | |
| 3075F | 0% | 2,958 | $0.00 | |
| 3080F | 0% | 869 | $0.00 | |
| 91301 | 0% | 282 | $0.00 | |
| 91307 | 0% | 281 | $0.00 | |
| 1123F | 0% | 532 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 218 | $0.00 |
| 74019 | 0% | 26 | $0.00 | |
| 1111F | 0% | 81 | $0.00 | |
| V5008 | Hearing screening | 0% | 12 | $0.00 |
| 90619 | 0% | 25 | $0.00 | |
| 99024 | 0% | 17 | $0.00 | |
| 99493 | 0% | 24 | $0.00 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 13 | $0.00 |
| 3078F | 0% | 22,379 | $0.00 | |
| 1159F | 0% | 51 | $0.00 | |
| 91300 | 0% | 2,034 | $0.00 | |
| 3077F | 0% | 1,571 | $0.00 | |
| 90633 | 0% | 1,508 | $0.00 | |
| 0502F | 0% | 2,185 | $0.00 | |
| 90685 | 0% | 602 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 88 | $0.00 |
| 3046F | 0% | 464 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 13 | $0.00 |
| 3051F | 0% | 463 | $0.00 | |
| 74018 | 0% | 18 | $0.00 | |
| 99354 | 0% | 18 | $0.00 | |
| 82374 | 0% | 12 | $0.00 | |
| 91312 | 0% | 88 | $0.00 | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 0% | 13 | $0.00 |
| 91313 | 0% | 37 | $0.00 | |
| 1160F | 0% | 14 | $0.00 | |
| 84520 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Mayo Clinic Health System-Southeast Minnesota Region | Albert Lea, MN | $37.49M |
| Mayo Clinic Health System-Southwest Minnesota Region | Mankato, MN | $28.51M |
| Mayo Clinic Health System-Southeast Minnesota Region | Albert Lea, MN | $21.76M |
| Mayo Clinic Health System-Southeast Minnesota Region | Albert Lea, MN | $12.58M |
| Mayo Clinic Health System-Fairmont | Fairmont, MN | $9.04M |
| Mayo Clinic Health System-Southeast Minnesota Region | Red Wing, MN | $6.56M |
| Mayo Clinic Health System-Fairmont | Fairmont, MN | $4.71M |
| Mayo Clinic Health System-Southeast Minnesota Region | Red Wing, MN | $4.42M |
| Mayo Clinic Health System-Southwest Minnesota Region | Waseca, MN | $2.72M |
| Mayo Clinic Health System-Southwest Minnesota Region | New Prague, MN | $1.41M |
| Mayo Clinic Health System-Lake City | Lake City, MN | $653K |
| Mayo Clinic Health System-Southeast Minnesota Region | Cannon Falls, MN | $520K |
| Mayo Clinic Health System-Lake City | Lake City, MN | $265K |
| Mayo Clinic Health System-Lake City | Lake City, MN | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.